Form 4: Nanophase Technologies Corp. Executive Kevin Cureton Increases Stake in Company
SEC Form 4 Filing
Chief Operating Officer Kevin Cureton recently purchased additional shares of Nanophase Technologies Corp., increasing his direct holdings.
Summary
- On September 23, 2024, Kevin Cureton, the Chief Operating Officer of Nanophase Technologies Corp., acquired 1,000 shares of common stock at $1.57 per share.
- He also acquired 3,716 shares of common stock at $1.4625 per share on the same day.
- Following these transactions, Cureton directly owns 192,212 shares of Nanophase Technologies Corp.
- Cureton also holds rights to purchase various blocks of common stock at prices ranging from $0.42 to $4.17, with expiration dates extending to 2030.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to insider buying, which often signals confidence in the company's prospects. However, it's a single transaction and doesn't provide a comprehensive view.
Positives
- An officer increasing their stake in the company may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that company executives believe the company's stock is undervalued.
Stakeholder Impact
- The increased stake of a key executive could positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 02/18/2016 | Date exercisable for common stock (right to purchase) at $0.44, expiring 02/18/2025 |
| 02/23/2017 | Date exercisable for common stock (right to purchase) at $0.42, expiring 02/23/2026 |
| 02/21/2018 | Date exercisable for common stock (right to purchase) at $0.68, expiring 02/21/2027 |
| 05/23/2019 | Date exercisable for common stock (right to purchase) at $0.82, expiring 05/23/2028 |
| 05/22/2020 | Date exercisable for common stock (right to purchase) at $0.51, expiring 05/22/2029 |
| 06/18/2021 | Date exercisable for common stock (right to purchase) at $0.45, expiring 06/18/2027 |
| 12/28/2022 | Date exercisable for common stock (right to purchase) at $4.17, expiring 12/28/2028 |
| 12/20/2023 | Date exercisable for common stock (right to purchase) at $1.165, expiring 12/20/2029 |
| 09/23/2024 | Date of common stock purchase transactions. |
| 12/27/2024 | Date exercisable for common stock (right to purchase) at $0.61, expiring 12/27/2030 |
| 09/25/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.